Vestmark Advisory Solutions’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $567K | Buy |
+14,341
| New | +$567K | 0.01% | 596 |
|
|
2023
Q3 | – | Sell |
-23,623
| Closed | -$969K | – | 652 |
|
|
2023
Q2 | $969K | Buy |
23,623
+4,556
| +24% | +$187K | 0.04% | 454 |
|
|
2023
Q1 | $681K | Buy |
19,067
+465
| +2% | +$16.6K | 0.03% | 522 |
|
|
2022
Q4 | $703K | Sell |
18,602
-6,597
| -26% | -$249K | 0.03% | 502 |
|
|
2022
Q3 | $1.12M | Buy |
25,199
+1,604
| +7% | +$71K | 0.06% | 354 |
|
|
2022
Q2 | $874K | Buy |
23,595
+4,434
| +23% | +$164K | 0.05% | 402 |
|
|
2022
Q1 | $710K | Buy |
19,161
+583
| +3% | +$21.6K | 0.04% | 443 |
|
|
2021
Q4 | $565K | Sell |
18,578
-1,455
| -7% | -$44.3K | 0.03% | 509 |
|
|
2021
Q3 | $672K | Buy |
20,033
+146
| +0.7% | +$4.9K | 0.05% | 408 |
|
|
2021
Q2 | $793K | Sell |
19,887
-6,622
| -25% | -$264K | 0.06% | 370 |
|
|
2021
Q1 | $1.19M | Buy |
26,509
+6,634
| +33% | +$298K | 0.11% | 252 |
|
|
2020
Q4 | $1.12M | Sell |
19,875
-661
| -3% | -$37.4K | 0.13% | 221 |
|
|
2020
Q3 | $974K | Sell |
20,536
-82
| -0.4% | -$3.89K | 0.13% | 213 |
|
|
2020
Q2 | $1.22M | Sell |
20,618
-1,209
| -6% | -$71.3K | 0.19% | 151 |
|
|
2020
Q1 | $1.03M | Sell |
21,827
-788
| -3% | -$37.3K | 0.2% | 155 |
|
|
2019
Q4 | $1.37M | Sell |
22,615
-758
| -3% | -$45.8K | 0.28% | 130 |
|
|
2019
Q3 | $1.4M | Sell |
23,373
-1,000
| -4% | -$59.9K | 0.23% | 135 |
|
|
2019
Q2 | $1.57M | Buy |
24,373
+266
| +1% | +$17.1K | 0.27% | 112 |
|
|
2019
Q1 | $1.96M | Buy |
+24,107
| New | +$1.96M | 0.35% | 75 |
|